Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheryl Ho

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2023
Economic impact of using risk models for eligibility selection to the International lung screening TrialSonya Cressman, Marianne F Weber, Preston J Ngo, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2025
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)William J Phillips, Luna Jia Zhan, Deepro Chowdhury, et al.
BMJ Open|July 5, 2024
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET CollaborationKristy P Robledo, Shilo Lefresne, Yu Yang Soon, et al.
Canadian Journal of Kidney Health and Disease|November 25, 2021
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research ProtocolAnshika Jain, Ryan Huang, Jasmine Lee, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancersJanessa Laskin, Steven Jones, Samuel Aparicio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2017
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)Solange Peters, Scott Gettinger, Melissa L Johnson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2026
Osimertinib and stereotactic radiosurgery for brain metastases in EGFR mutated lung cancer - The STARLET joint analysis of OUTRUN and LUOSICNS randomised trialsChee Khoon Lee, Shilo Lefresne, Yu Yang Soon, et al.
The Lancet. Oncology|December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemicVictor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Lung Cancer (Amsterdam, Netherlands)|January 2, 2023
Economic impact of using risk models for eligibility selection to the International lung screening TrialSonya Cressman, Marianne F Weber, Preston J Ngo, et al.
Lung Cancer (Amsterdam, Netherlands)|November 22, 2025
Treatment and outcomes of limited stage small cell lung cancer in the Canadian small cell lung cancer database (CASCADE)William J Phillips, Luna Jia Zhan, Deepro Chowdhury, et al.
BMJ Open|July 5, 2024
Protocol for a systematic review with prospective individual patient data meta-analysis in EGFR-mutant NSCLC with brain metastases to assess the effect of SRS+osimertinib compared to osimertinib alone: the STARLET CollaborationKristy P Robledo, Shilo Lefresne, Yu Yang Soon, et al.
Canadian Journal of Kidney Health and Disease|November 25, 2021
A Canadian Study of Cisplatin Metabolomics and Nephrotoxicity (ACCENT): A Clinical Research ProtocolAnshika Jain, Ryan Huang, Jasmine Lee, et al.
Cold Spring Harbor Molecular Case Studies|May 6, 2016
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancersJanessa Laskin, Steven Jones, Samuel Aparicio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2017
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH)Solange Peters, Scott Gettinger, Melissa L Johnson, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 14, 2026
Osimertinib and stereotactic radiosurgery for brain metastases in EGFR mutated lung cancer - The STARLET joint analysis of OUTRUN and LUOSICNS randomised trialsChee Khoon Lee, Shilo Lefresne, Yu Yang Soon, et al.
The Lancet. Oncology|December 1, 2022
International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemicVictor Ho-Fun Lee, Marlinda Adham, Wala Ben Kridis, et al.
Pageof 12